Anna David MBChB, PhD, MRCOG


Professor Anna David is a consultant in Obstetrics and Maternal / Fetal Medicine at UCLH. Joining University College London (UCL) in 2000 from Queen Charlotte’s Hospital, Professor David was awarded a PhD for her work on fetal gene therapy for treatment of early onset genetic disease in 2005 and then trained in Maternal Fetal Medicine at UCLH under Professor Charles Rodeck. In 2008, she was awarded a prestigious UK HEFCE/Department of Health-funded Senior Clinical Lectureship in women’s health at UCL and UCLH when she took up a consultant post. 

Professor David offers a range of diagnostic and therapeutic services in the Fetal Medicine Unit at UCLH. She specialises in cases where the baby has a structural anomaly, a genetic condition, or when the baby’s growth is poor (fetal growth restriction). She has close links with the talented UCLH neonatal team, that are expert in caring for the smallest preterm infants. Professor David set up the Preterm Birth clinical service at UCLH in 2008, which is now one of the busiest in the UK, providing continuity of care in a nurturing environment. The comprehensive service offers pre-conceptual counselling, a wide range of cerclage and other treatments, and predictive tests. 

Professor David is Head of the Research Department of Maternal Fetal Medicine at the Institute for Women's Health, UCL. With funding from the European Commission, her team is developing new treatments for fetal growth restriction using maternal gene therapy and is pioneering the first clinical trial of in utero stem cell transplantation for brittle bone disease. She has won awards for her mentorship of academic trainees and colleagues and is a Fellow of the Royal College of Obstetricians and Gynaecologists.